메뉴 건너뛰기




Volumn 4, Issue 5, 2009, Pages 578-585

Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: Coexpression with VEGFR-3 and PDGF-b predicts poor survival

Author keywords

Angiogenesis; B FGF; FGF2; FGFR; NSCLC; Stroma

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PLATELET DERIVED GROWTH FACTOR B; VASCULOTROPIN RECEPTOR 3; FGFR1 PROTEIN, HUMAN; TUMOR MARKER;

EID: 67651165437     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31819f2e38     Document Type: Article
Times cited : (66)

References (32)
  • 2
    • 0026573360 scopus 로고
    • The effect of surgical treatment on survival from early lung cancer
    • Implications for screening
    • Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 1992;101:1013-1018.
    • (1992) Chest , vol.101 , pp. 1013-1018
    • Flehinger, B.J.1    Kimmel, M.2    Melamed, M.R.3
  • 3
    • 0030912190 scopus 로고    scopus 로고
    • Revisions in the International System for Staging Lung Cancer
    • Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-11707
    • (1997) Chest , vol.111 , pp. 1710-11707
    • Mountain, C.F.1
  • 7
    • 31344474845 scopus 로고    scopus 로고
    • Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
    • DOI 10.1016/j.lungcan.2005.09.005, PII S0169500205004988
    • Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 2006;51:143-158. (Pubitemid 43144358)
    • (2006) Lung Cancer , vol.51 , Issue.2 , pp. 143-158
    • Bremnes, R.M.1    Camps, C.2    Sirera, R.3
  • 8
    • 1542719213 scopus 로고    scopus 로고
    • Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC
    • DOI 10.1016/j.ejcts.2003.11.031, PII S1010794003007553
    • Iwasaki A, Kuwahara M, Yoshinaga Y, Shirakusa T. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Eur J Cardiothorac Surg 2004;25:443-448. (Pubitemid 38340585)
    • (2004) European Journal of Cardio-thoracic Surgery , vol.25 , Issue.3 , pp. 443-448
    • Iwasaki, A.1    Kuwahara, M.2    Yoshinaga, Y.3    Shirakusa, T.4
  • 9
    • 0037083515 scopus 로고    scopus 로고
    • Thymidine phosphorylase and vascular endothelial growth factor in patients with stage I lung adenocarcinoma
    • DOI 10.1002/cncr.10352
    • Kojima H, Shijubo N, Abe S. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma. Cancer 2002;94:1083-1093. (Pubitemid 34150864)
    • (2002) Cancer , vol.94 , Issue.4 , pp. 1083-1093
    • Kojima, H.1    Shijubo, N.2    Abe, S.3
  • 11
    • 0030217819 scopus 로고    scopus 로고
    • The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: An investigation of their expression as prognostic markers
    • DOI 10.1016/0959-8049(95)00620-6
    • Takanami I, Tanaka F, Hashizume T, et al. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur J Cancer 1996;32A: 1504-1509. (Pubitemid 26279115)
    • (1996) European Journal of Cancer Part A , vol.32 , Issue.9 , pp. 1504-1509
    • Takanami, I.1    Tanaka, F.2    Hashizume, T.3    Kikuchi, K.4    Yamamoto, Y.5    Yamamoto, T.6    Kodaira, S.7
  • 12
    • 0343471392 scopus 로고    scopus 로고
    • Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas
    • DOI 10.1016/S0959-8049(96)00411-X, PII S095980499600411X
    • Volm M, Koomagi R, Mattern J, Stammler G. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas. Eur J Cancer 1997;33:691-693. (Pubitemid 27223759)
    • (1997) European Journal of Cancer Part A , vol.33 , Issue.4 , pp. 691-693
    • Volm, M.1    Koomagi, R.2    Mattern, J.3    Stammler, G.4
  • 13
    • 0032769996 scopus 로고    scopus 로고
    • The expression of basic fibroblast growth factor (bFGF) in tumor- associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression
    • DOI 10.1016/S0046-8177(99)90139-9
    • Guddo F, Fontanini G, Reina C, Vignola AM, Angeletti A, Bonsignore G. The expression of basic fibroblast growth factor (bFGF) in tumorassociated stromal cells and vessels is inversely correlated with nonsmall cell lung cancer progression. Hum Pathol 1999;30:788-794. (Pubitemid 29325785)
    • (1999) Human Pathology , vol.30 , Issue.7 , pp. 788-794
    • Guddo, F.1    Fontanini, G.2    Reina, C.3    Vignola, A.M.4    Angeletti, A.5    Bonsignore, G.6
  • 15
    • 0035985171 scopus 로고    scopus 로고
    • Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients
    • DOI 10.1016/S0169-5002(02)00027-2, PII S0169500202000272
    • Brattstrom D, Bergqvist M, Hesselius P, et al. Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients. Lung Cancer 2002;37:57-63. (Pubitemid 34621459)
    • (2002) Lung Cancer , vol.37 , Issue.1 , pp. 57-63
    • Brattstrom, D.1    Bergqvist, M.2    Hesselius, P.3    Larsson, A.4    Lamberg, K.5    Wernlund, J.6    Brodin, O.7    Wagenius, G.8
  • 16
    • 0347931821 scopus 로고    scopus 로고
    • Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer
    • DOI 10.1016/j.lungcan.2003.07.007
    • Brattstrom D, Bergqvist M, Hesselius P, Larsson A, Wagenius G, Brodin O. Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer. Lung Cancer 2004;43: 55-62. (Pubitemid 38096292)
    • (2004) Lung Cancer , vol.43 , Issue.1 , pp. 55-62
    • Brattstrom, D.1    Bergqvist, M.2    Hesselius, P.3    Larsson, A.4    Wagenius, G.5    Brodin, O.6
  • 18
    • 0035144946 scopus 로고    scopus 로고
    • Increased serum levels of basic fibroblast growth factor in lung cancer patients: Relevance to response of therapy and prognosis
    • DOI 10.1016/S0169-5002(00)00187-2, PII S0169500200001872
    • Ueno K, Inoue Y, Kawaguchi T, Hosoe S, Kawahara M. Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis. Lung Cancer 2001;31: 213-219. (Pubitemid 32107018)
    • (2001) Lung Cancer , vol.31 , Issue.2-3 , pp. 213-219
    • Ueno, K.1    Inoue, Y.2    Kawaguchi, T.3    Hosoe, S.4    Kawahara, M.5
  • 19
    • 34948848203 scopus 로고    scopus 로고
    • Why targeted therapy hasn't worked in advanced cancer
    • Arbiser JL. Why targeted therapy hasn't worked in advanced cancer. J Clin Invest 2007;117:2762-2765.
    • (2007) J Clin Invest , vol.117 , pp. 2762-2765
    • Arbiser, J.L.1
  • 23
    • 58049193595 scopus 로고    scopus 로고
    • VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells
    • Donnem T, Al-Shibli K, Al-Saad S, Delghandi MP, Busund LT, Bremnes RM. VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells. Lung Cancer 2009;63:277-283.
    • (2009) Lung Cancer , vol.63 , pp. 277-283
    • Donnem, T.1    Al-Shibli, K.2    Al-Saad, S.3    Delghandi, M.P.4    Busund, L.T.5    Bremnes, R.M.6
  • 26
    • 30144443269 scopus 로고    scopus 로고
    • Paradoxical roles of the immune system during cancer development
    • DOI 10.1038/nrc1782
    • de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6: 24-37. (Pubitemid 43053650)
    • (2006) Nature Reviews Cancer , vol.6 , Issue.1 , pp. 24-37
    • De Visser, K.E.1    Eichten, A.2    Coussens, L.M.3
  • 27
    • 52649163840 scopus 로고    scopus 로고
    • Prognostic impact of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
    • Al-Shibli K, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Prognostic impact of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 2008;15:5220-5227.
    • (2008) Clin Cancer Res , vol.15 , pp. 5220-5227
    • Al-Shibli, K.1    Donnem, T.2    Al-Saad, S.3    Persson, M.4    Bremnes, R.M.5    Busund, L.T.6
  • 28
    • 0034638923 scopus 로고    scopus 로고
    • Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
    • DOI 10.1038/sj.onc.1203969
    • Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000;19:6122-6129. (Pubitemid 32059462)
    • (2000) Oncogene , vol.19 , Issue.53 , pp. 6122-6129
    • Saaristo, A.1    Karpanen, T.2    Alitalo, K.3
  • 32
    • 30744477450 scopus 로고    scopus 로고
    • Lymphangiogenesis in development and human disease
    • DOI 10.1038/nature04480, PII NATURE04480
    • Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438:946-953. (Pubitemid 43093960)
    • (2005) Nature , vol.438 , Issue.7070 , pp. 946-953
    • Alitalo, K.1    Tammela, T.2    Petrova, T.V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.